Eliminating the need for daily injections: Crystec and Biosidus aim to disrupt delivery of biotherapeutics

Crystec Ltd and Biosidus SA are teaming up to focus on enhancing the delivery and performance of biotherapeutics.

Related Keywords

Argentina ,Emily Bevis , ,United Kingdom Based ,Bio Developments ,Needle Free ,Osteoporosis ,Particle Engineering ,